Cell-type specific Cas9 delivery (Hamilton, NBT 2024)
Work from Jennifer Doudna's lab shows the ability to target CRISPR payloads to specific cell types. They create virus-like particles decorated with small antibodies that bind to proteins on target cells. This strategy enables them to create CAR T cells in vivo, some of which also containing a second gene edit from Cas9.